None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Those who satisfy all of the following conditions 1)Healthy babies (male and female) aged 28 days-old to 11 months-old. 2)Subjects who have their protector (parents or guardians) that are able to show their willingness of participating to the test, and that are able to obtain written consent to participate in the test after understanding explanation of test. 3)Subjects and their protectors(parents or guardians) who are able to come to the institution for all inspections.
Exclusion criteria
Exclusion criteria: 1)Premature babies. 2)Subjects with birth weight >2,500g. 3)Subjects who have severe eczema infantile. 4)Subjects who have skin symptom such as atopic dermatitis. 5)Subjects who have trauma on the part that uses the test sample. 6)Subjects who have possibility to take a lot of sunlight. 7)Subjects who are participating in clinical tests and use tests that apply cosmetic, quasi-drugs and others. 8)Subjects who have allergic symptoms against external medicine, cosmetic, quasi-drugs and others in the past. 9)Subjects who have previous and/or current medical history of serious disease in liver, kidney, myocardial infarction. 10)Subject who are going to hospital and being accepted medical treatment due to disease. 11)Subjects who have their family that are working for cosmetic companies and pharmaceutical companies. 12)Others who have been determined ineligible by investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Doctor's findings such as dryness or scales, erythema, papules, scratch marks on the whole body prior to starting test and at four weeks after test start. | — |
Secondary
| Measure | Time frame |
|---|---|
| *Doctor's findings such as dryness or scales, erythema, papules, scratch marks on the whole body prior to starting test and at two weeks after test start. *Measuring stratum corneum water content of skin, transepidermal water transpiration amount of skin prior to starting test and at two and four weeks after test start. | — |
Countries
Japan
Contacts
Inforward, inc EBISU skin research center